Skip to content
Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals, Inc. technical analysis

IONSHealthcare Updated daily

Technical analysis of Ionis Pharmaceuticals, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.

What is Ionis Pharmaceuticals, Inc.

Ionis Pharmaceuticals is a biotechnology company that develops and commercializes RNA-targeted medicines for the treatment of rare genetic diseases and chronic conditions. The company offers approved products such as SPINRAZA for spinal muscular atrophy, QALSODY for amyotrophic lateral sclerosis, and several medicines for rare metabolic and neurological disorders. The company also has multiple therapeutic candidates in clinical development at various stages.

Description generated automatically from public sources; it may be inaccurate or out of date.

Ionis Pharmaceuticals, Inc.: latest session data

Closing values for September 3, 2026, computed on the last 12 months of prices.

Close58.13 $
Change−5.22%
RSI (14)44.9
MACD0.258
ADX17.5
Volatility (ATR)3.59%
Volume vs 20-avg197%
12-month high86.74 $
12-month low50.01 $

Moving averages

21 sessions

59.18 $

−1.77%

50 sessions

61.64 $

−5.70%

200 sessions

73.50 $

−20.91%

Session levels

s2

58.97

Support

s1

60.15

Support

pivot

60.96

Pivot

r1

62.14

Resistance

r2

62.95

Resistance

How to read it

In the September 3, 2026 session Ionis Pharmaceuticals, Inc. closed lower at 58.13 $, −5.22% versus the previous session.

The price sits below every moving average observed: −1.77% against the 21-session average, −5.70% against the 50 and −20.91% against the 200.

The 14-period RSI reads 44.9, in neutral territory.

MACD stands at 0.258 against a signal line at 0.089: the histogram is positive (+0.168).

ADX reads 17.5, indicating weak directionality.

Levels computed on the latest session place supports at 60.15 and 58.97 $ and resistances at 62.14 and 62.95 $, around a pivot of 60.96.

The average daily range (ATR) is 2.088 $, or 3.59% of price.

Turnover was 4.3M shares, 197% of the 20-session average.

Over the last twelve months the price ranged between 50.01 and 86.74 $, and today stands −32.98% from the period high.

Measures computed on closing prices. They describe the past; they are not forecasts.

Open the full analysis of Ionis Pharmaceuticals, Inc.

Score, Elliott Waves, moving averages and technical indicators — free, no card

If you're not registered we'll ask you to sign in (free), then open the IONS analysis.

How Montbon’s technical analysis works

Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.

Elliott Waves

Wave counting to frame the price structure.

MTF moving averages

Moving averages across timeframes to read the trend.

0–100 score

A technical summary of the setup, updated daily.

Read the full Montbon Score methodology →

FAQ about Ionis Pharmaceuticals, Inc.

How is Ionis Pharmaceuticals, Inc. analysed technically?

Technical analysis of Ionis Pharmaceuticals, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.

Which timeframes are used for Ionis Pharmaceuticals, Inc.?

The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.

What are Elliott Waves applied to Ionis Pharmaceuticals, Inc.?

Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Ionis Pharmaceuticals, Inc. it helps frame the technical structure of the historical chart and is not a forecast.

Other tickers to analyse

Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.

Are you an issuer and want a correction or removal? Write to info@montbon.com.